EUVIMEDDescoperă EUVIMED
Crossref

Effects of Mebendazole and Flutamide Combination in Prostate Cancer Cell Lines: a Comprehensive in Vitro Analysis

Mohammad Reza Fattahi, Diana Taheri, Seyed Hassan Inanloo, Akram Mirzaei, Helia Azodian Ghajar, Leonardo Oliveira Reis, Seyed Mohammad Kazem Aghamir

Cellular Physiology and Biochemistry · 2026-08-23 · 60 (4) · 458-472

DOI: 10.33594/000000883 ↗

At a glance

Journal article in Cellular Physiology and Biochemistry, published online on 2026-08-23. Written by Mohammad Reza Fattahi and 6 co-authors. Institution: Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. Major MEDLINE topics: Mebendazole, Flutamide, Antineoplastic Agents.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background/Aims: The aim of this research was to use Mebendazole as an anticancer candidate to reduce the dose of Flutamide and reduce its side effects.

Method

In this in vitro study, we evaluated the effect of Mebendazole, Flutamide and Mebendazole-Flutamide combination therapy in LNCaP, DU145 and PC3 cell lines as representatives of human prostate cancer. The assessment includes scratch-wound assay, colony formation assay, flow cytometric analysis of apoptosis and DNA cell cycle, real-time PCR (BAX/BCL2, E-cadherin, N-cadherin, Snail, HIF1α, VEGFC, KLK3, TUBB1 and TUBB3 genes).

Results

To determine IC50 levels, cell lines were exposed to different concentration of the drugs. Our data indicated that IC50 values for Mebendazole (55μM) and for 3 cell lines and flutamide (12μM and 10μM) for PC3 and LNCaP/DU145 respectively, with MTT were approved by flow cytometry in a dose and time-dependent manner which was as a consequence of cell cycle arrest at G1/S phase. Furthermore, for the first time, we offered that combination of mebendazole and flutamide produced a greater inhibitory effect on cell viability, colony formation, and migration than either agent alone at the tested concentrations. The combination treatment also increased apoptotic cell populations and upregulated the BAX/BCL2 mRNA ratio and E-cadherin expression in all three cell lines (P

Subjects

MeSH terms (MEDLINE)

MebendazoleFlutamideAntineoplastic AgentsHumansMaleProstatic NeoplasmsApoptosisCell Line, TumorCell ProliferationCell SurvivalCell Movement

Author keywords

Flutamide ; Mebendazole ; Combination therapy ; Prostate cancer

Substances

MebendazoleFlutamideAntineoplastic Agents

Authors and institutions

  • Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pathology, Isfahan Kidney Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Urology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, Campinas, Sao Paulo, Brazil.

Cite

APA

Fattahi, M. R., Taheri, D., Inanloo, S. H., Mirzaei, A., Azodian Ghajar, H., Reis, L. O., & Aghamir, S. M. K. (2026). Effects of Mebendazole and Flutamide Combination in Prostate Cancer Cell Lines: a Comprehensive in Vitro Analysis. Cellular Physiology and Biochemistry, 60(4), 458-472. https://doi.org/10.33594/000000883

Vancouver

Fattahi MR, Taheri D, Inanloo SH, Mirzaei A, Azodian Ghajar H, Reis LO, et al. Effects of Mebendazole and Flutamide Combination in Prostate Cancer Cell Lines: a Comprehensive in Vitro Analysis. Cellular Physiology and Biochemistry. 2026;60(4):458-472. doi:10.33594/000000883

BibTeX
@article{Fattahi2026,
  author = {Fattahi, Mohammad Reza and Taheri, Diana and Inanloo, Seyed Hassan and Mirzaei, Akram and Azodian Ghajar, Helia and Reis, Leonardo Oliveira and Aghamir, Seyed Mohammad Kazem},
  title = {Effects of Mebendazole and Flutamide Combination in Prostate Cancer Cell Lines: a Comprehensive in Vitro Analysis},
  journal = {Cellular Physiology and Biochemistry},
  year = {2026},
  volume = {60},
  number = {4},
  pages = {458--472},
  doi = {10.33594/000000883}
}
Start for free →